Biblio
Export 335 results:
Author [ Title
Filters: First Letter Of Last Name is I [Clear All Filters]
“Primary Progressive Orofacial Apraxia: A Ten-Year Long Follow-Up Case Report.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1039-1045, 2016.
, “Prospective Memory Impairments in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates.”, J Alzheimers Dis, vol. 50, no. 2, pp. 425-41, 2016.
, “A Prototype for the Voice Analysis Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 473-481, 2018.
, “Psychological and Mnemonic Benefits of Nostalgia for People with Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1327-1344, 2018.
, “Psychological and Mnemonic Benefits of Nostalgia for People with Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1327-1344, 2018.
, “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
, “Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
, “Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer's Disease-Specific Signatures.”, J Alzheimers Dis, vol. 58, no. 1, pp. 139-145, 2017.
, , “Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1145-1156, 2017.
, “Rats Display Sexual Dimorphism in Phosphorylation of Brain Tau with Age.”, J Alzheimers Dis, vol. 82, no. 2, pp. 855-869, 2021.
, “Rbfox3/NeuN Regulates Alternative Splicing of Tau Exon 10.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1695-1704, 2018.
, “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Recent Increases in Hippocampal Tau Pathology in the Aging Japanese Population: The Hisayama Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 613-624, 2017.
, “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
, “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
, “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
, “Relation of a Socioeconomic Index with Cognitive Function and Neuroimaging in Hypertensive Individuals.”, J Alzheimers Dis, vol. 82, no. 2, pp. 815-826, 2021.
, “Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 3, pp. 781-791, 2018.
, “The Relationship Between Prior Cancer Diagnosis and All-Cause Dementia Progression Among US Adults.”, J Alzheimers Dis, vol. 88, no. 2, pp. 521-535, 2022.
, “Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.”, J Alzheimers Dis, vol. 59, no. 3, pp. 815-849, 2017.
, “A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).”, J Alzheimers Dis, vol. 63, no. 4, pp. 1509-1522, 2018.
, “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
, “The Road Less Traveled: Alternative Pathways for Action-Verb Processing in Parkinson's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1429-1435, 2017.
,